Curia - Accelerating therapies from discovery to commercialization with flexible, scalable CDMO solutions.

Reset all filters
01 5Curia
02 1TAPI Technology & API Services
03 1Aurobindo Pharma Limited
04 1Chongqing Shenghuaxi Pharma. Co., Ltd
05 1FangYuan Pharmaceutical
06 1Fresenius Kabi AB Brunna
07 2Fuan Pharmaceutical
08 1Orchid Pharma
Reset all filters
01 2AZTREONAM
02 2AZTREONAM ALFA FORM
03 2AZTREONAM BETA FORM
04 1AZTREONAM HYDRATED NON-STERILE ALPHA-FORM
05 1AZTREONAM NON STERILE ALPHA
06 3AZTREONAM USP
07 1AZTREONAM USP (NON-STERILE BULK DRUG SUBSTANCE)
08 1AZTREONAM, NON-STERILE BULK DRUG SUBSTANCE
Reset all filters
01 4China
02 2India
03 1Israel
04 1Sweden
05 5U.S.A
Reset all filters
01 10Active
02 3Inactive
Reset all filters
01 7Complete
02 6Blank
Curia - Accelerating therapies from discovery to commercialization with flexible, scalable CDMO solutions.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 17184
Submission : 2004-02-23
Status : Active
Type : II
TAPI, a leading global supplier of APIs, provides over 350 products and customized CDMO solutions for every stage of development.
GDUFA
DMF Review : Complete
Rev. Date : 2012-12-24
Pay. Date : 2012-12-03
DMF Number : 19342
Submission : 2006-04-11
Status : Active
Type : II
Curia - Accelerating therapies from discovery to commercialization with flexible, scalable CDMO solutions.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 38055
Submission : 2023-05-12
Status : Active
Type : II
Curia - Accelerating therapies from discovery to commercialization with flexible, scalable CDMO solutions.
GDUFA
DMF Review : Complete
Rev. Date : 2019-08-13
Pay. Date : 2019-06-03
DMF Number : 33762
Submission : 2019-04-09
Status : Active
Type : II
Curia - Accelerating therapies from discovery to commercialization with flexible, scalable CDMO solutions.
GDUFA
DMF Review : Complete
Rev. Date : 2019-07-09
Pay. Date : 2019-05-17
DMF Number : 33731
Submission : 2019-04-05
Status : Active
Type : II
Curia - Accelerating therapies from discovery to commercialization with flexible, scalable CDMO solutions.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 39731
Submission : 2024-05-21
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2023-09-12
Pay. Date : 2023-07-31
DMF Number : 38649
Submission : 2023-07-31
Status : Active
Type : II

GDUFA
DMF Review : Complete
Rev. Date : 2014-07-15
Pay. Date : 2013-10-30
DMF Number : 26856
Submission : 2013-10-18
Status : Active
Type : II

GDUFA
DMF Review : Complete
Rev. Date : 2025-05-23
Pay. Date : 2025-04-18
DMF Number : 40841
Submission : 2025-04-24
Status : Active
Type : II

GDUFA
DMF Review : Complete
Rev. Date : 2014-05-28
Pay. Date : 2013-09-30
DMF Number : 27508
Submission : 2013-09-11
Status : Active
Type : II

51
PharmaCompass offers a list of Aztreonam API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Aztreonam manufacturer or Aztreonam supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Aztreonam manufacturer or Aztreonam supplier.
A Aztreonam manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Aztreonam, including repackagers and relabelers. The FDA regulates Aztreonam manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Aztreonam API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Aztreonam manufacturers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PhamaCompass.
A Aztreonam supplier is an individual or a company that provides Aztreonam active pharmaceutical ingredient (API) or Aztreonam finished formulations upon request. The Aztreonam suppliers may include Aztreonam API manufacturers, exporters, distributors and traders.
click here to find a list of Aztreonam suppliers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PharmaCompass.
A Aztreonam DMF (Drug Master File) is a document detailing the whole manufacturing process of Aztreonam active pharmaceutical ingredient (API) in detail. Different forms of Aztreonam DMFs exist exist since differing nations have different regulations, such as Aztreonam USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Aztreonam DMF submitted to regulatory agencies in the US is known as a USDMF. Aztreonam USDMF includes data on Aztreonam's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Aztreonam USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Aztreonam suppliers with USDMF on PharmaCompass.
We have 8 companies offering Aztreonam
Get in contact with the supplier of your choice: